08/15/2025
7:24 AM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2025
11:17 AM | BioCryst Pharmaceuticals (Subject)
HEGGIE THERESA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2025
6:10 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2025
6:12 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
6:03 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2025
3:35 PM | BioCryst Pharmaceuticals (Issuer)
Ghias Babar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
6:10 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
5:57 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
3:18 PM | BioCryst Pharmaceuticals (Issuer)
Frank Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BCRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/16/2025
3:19 PM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:19 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:20 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:21 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:21 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:21 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:22 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
6:27 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
3:05 PM | BioCryst Pharmaceuticals (Issuer)
Frank Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:08 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
8:31 AM | Avoro Capital Advisors LLC (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
6:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
3:31 PM | BioCryst Pharmaceuticals (Issuer)
Frank Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
6:11 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:02 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
5:26 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:01 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:09 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
6:13 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
6:20 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:19 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:11 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:05 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:16 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:22 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:10 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:03 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Winning the AI War (Ad) What’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry and Jeff Brown, it all traces back to one force: artificial intelligence.
Trump has declared AI a national priority—and is using emergency powers to funnel trillions into the companies building the digital and energy infrastructure behind America’s AI dominance. This isn’t speculation—it’s strategic deployment, already in motion. Click here to watch the urgent broadcast and discover two stocks they believe are best positioned to |
12/17/2024
3:06 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:35 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:23 PM | BioCryst Pharmaceuticals (Subject)
Hutson Nancy J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:06 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
9:52 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
9:25 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/05/2024
4:19 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:18 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:52 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/02/2024
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
6:11 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
11:09 AM | BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
MarketBeat All Access